Atopic Dermatitis: Using Ceramide-Based Skincare Products? Here’s What L’Oréal’s Clinical Research Says

LOréal Dermatological Beauty India announced the results of a clinical study establishing the efficacy and tolerance of a ceramide-based moisturizer having unique multivesicular emulsion (MVE) technology, on Indian patients suffering from mild to moderate atopic dermatitis.

What’s Atopic dermatitis?

Atopic dermatitis (AD), also known as eczema, is a chronic inflammatory skin condition characterized by dry, itchy, inflamed skin. It can lead to physical discomfort, sleep disturbances, and limitations in daily activities impacting the quality of life overall. Besides visible symptoms, the condition also impacts social interactions, self-esteem, leading to psychological distress.

More about the research

The research led by renowned dermatologist, Dr Neena Khanna, MBBS, MD, FAMS, Prof & Head, Department of Dermatology Amrita Institute of Medical Sciences & Research studied more than 100 patients with mild to moderate Atopic Dermatitis for six weeks (1 week wash out*, 4 weeks treatment phase with ceramide containing moisturiser & 1-week treatment-free follow up phase).

Lotion vs moisturiser: What is the difference and when to use them

Effects of moisturiser start as early as 15 minutes

While presenting the study, principal Investigator Dr. Khanna said, “The notable conclusions from the study were – a significant improvement in the severity of atopic skin symptoms and an improvement in skin hydration. The study also indicates that the effects of this moisturiser start as early as 15 minutes after 1st application and continue for at least 1 week after stopping the use of the moisturiser, in the follow-up phase.”